{"id":2220,"date":"2024-11-07T09:30:08","date_gmt":"2024-11-07T12:30:08","guid":{"rendered":"https:\/\/blog.verifarma.com\/home\/?p=2220"},"modified":"2024-11-07T09:30:08","modified_gmt":"2024-11-07T12:30:08","slug":"migration-serialization-traceability-providers-european-pharmaceutical-industry-l4","status":"publish","type":"post","link":"https:\/\/blog.verifarma.com\/home\/trazabilidad-en\/migration-serialization-traceability-providers-european-pharmaceutical-industry-l4\/","title":{"rendered":"Why So Many Companies in Europe Are Reconsidering Their Traceability and Serialization Providers"},"content":{"rendered":"<div class=\"fusion-fullwidth fullwidth-box fusion-builder-row-1 fusion-flex-container nonhundred-percent-fullwidth non-hundred-percent-height-scrolling\" style=\"background-color: rgba(255,255,255,0);background-position: center center;background-repeat: no-repeat;border-width: 0px 0px 0px 0px;border-color:#e2e2e2;border-style:solid;\" ><div class=\"fusion-builder-row fusion-row fusion-flex-align-items-flex-start\" style=\"max-width:1248px;margin-left: calc(-4% \/ 2 );margin-right: calc(-4% \/ 2 );\"><div class=\"fusion-layout-column fusion_builder_column fusion-builder-column-0 fusion_builder_column_1_1 1_1 fusion-flex-column\"><div class=\"fusion-column-wrapper fusion-flex-justify-content-flex-start fusion-content-layout-column\" style=\"background-position:left top;background-repeat:no-repeat;-webkit-background-size:cover;-moz-background-size:cover;-o-background-size:cover;background-size:cover;padding: 0px 0px 0px 0px;\"><div class=\"fusion-text fusion-text-1\"><h1><strong>Why So Many Companies in Europe Are Reconsidering Their Traceability and Serialization Providers<\/strong><\/h1>\n<p>The pharmaceutical industry in Europe faces the challenge of meeting strict anti-counterfeiting regulations designed to ensure patient safety. However, in the rush to comply with the European serialization system\u2019s mandatory implementation date of February 2019, many companies opted for quick solutions that, in the long run, have not always been sustainable. Others chose solutions with excessive functionalities and costs compared to the contracting laboratory\u2019s requirements. Today, over five years after the regulation\u2019s implementation, many companies are re-evaluating their traceability providers to find alternatives that are efficient, scalable, and sustainable over time.<\/p>\n<h2><strong>Reasons for Migrating to New Serialization and Traceability Providers<\/strong><\/h2>\n<p>Contract reviews have become more common in the sector due to issues such as:<\/p>\n<ul>\n<li>High serialization costs, which impact profitability as expenses increase over time.<\/li>\n<li>Insufficient customer service that fails to respond quickly to companies\u2019 needs, compromising regulatory and operational compliance.<\/li>\n<li>Relative importance of the provider: smaller intermediate laboratories are often dissatisfied with global providers due to the perceived lack of attention they receive.<\/li>\n<li>Technological limitations that hinder adaptation to new requirements or increase customization costs.<\/li>\n<li>Lack of long-term vision and limited sustainability, driving companies to seek providers capable of guaranteeing an effective, cost-efficient solution over time.<\/li>\n<\/ul>\n<h2><strong>How to Evaluate a Future Serialization and Aggregation Provider<\/strong><\/h2>\n<p>Selecting a Level 4 serialization and traceability provider is key to ensuring a successful transition and improving supply chain control and efficiency. Here are some criteria to correctly evaluate potential candidates:<\/p>\n<ol>\n<li>\n<h3><strong>Proposal Assessment: A Solution Tailored to the Company\u2019s Needs<\/strong><\/h3>\n<p>A provider should demonstrate an understanding of the company\u2019s needs and a willingness to customize the solution based on factors such as:<\/p>\n<ul>\n<li>Type and volume of production<\/li>\n<li>Specific production processes and timelines<\/li>\n<li>Existing infrastructure and hardware<\/li>\n<li>Implementation schedule<\/li>\n<li>Total costs and budget<\/li>\n<\/ul>\n<p>It is essential for the provider\u2019s proposal to be transparent regarding costs, including direct and indirect costs such as:<\/p>\n<ul>\n<li>System maintenance, updates, and support<\/li>\n<li>Staff and end-user training<\/li>\n<li>Computer validation<\/li>\n<\/ul>\n<p>This breakdown allows for more accurate comparison of options and the selection of a solution that offers the best value in both the short and long term.<\/li>\n<li>\n<h3><strong>Quality Technical Support and Assistance<\/strong><\/h3>\n<p>To ensure operational continuity, the serialization provider should offer efficient technical support, ideally with:<\/p>\n<ul>\n<li>Assistance in the same language<\/li>\n<li>Extended coverage hours<\/li>\n<li>Technicians trained in problem detection and resolution<\/li>\n<\/ul>\n<p>Any delay in serialization and traceability can impact product entry into the market, so having a nearby, accessible, and well-prepared team is essential.<\/li>\n<li>\n<h3><strong>Verification of References and Success Stories<\/strong><\/h3>\n<p>Before making a decision, it is crucial to investigate the provider\u2019s track record. Reviewing references and previous success stories can offer a clear view of their performance in similar situations and provide insight into other clients\u2019 satisfaction. This analysis helps select a reliable provider capable of meeting the specific challenges of the sector.<\/li>\n<\/ol>\n<h2><strong>Benefits of Switching to a New Level 4 and Level 5 Serialization and Traceability Provider<\/strong><\/h2>\n<p>Migrating to a specialized provider can offer significant advantages:<\/p>\n<ul>\n<li><strong>Costs aligned with current needs<\/strong>: as risks and unknowns have decreased over time.<\/li>\n<li><strong>Greater efficiency and scalability<\/strong>: more advanced solutions enable smooth operations and adaptability to future regulatory changes.<\/li>\n<li><strong>Security and continuity<\/strong>: today\u2019s migration processes are secure and do not disrupt data flow or regulatory compliance.<\/li>\n<li><strong>Improved post-implementation service<\/strong>: proactive customer support simplifies incident management and ensures a positive user experience.<\/li>\n<li><\/li>\n<\/ul>\n<h2><strong>Conclusion: Towards Efficient and Sustainable Traceability<\/strong><\/h2>\n<p>In Europe, the traceability market has grown in knowledge and experience. Pharmaceutical companies are re-evaluating their options and migrating to Level 4 providers who offer a combination of efficiency, sustainability, and continuous support. This change can make a crucial difference in profitability and long-term regulatory compliance, ensuring robust and efficient processes.<\/p>\n<p>If you want to learn more about how traceability migration can benefit your company, Verifarma is ready to help you find the right solution to optimize your processes.<\/p>\n<\/div><\/div><\/div><style type=\"text\/css\">.fusion-body .fusion-builder-column-0{width:100% !important;margin-top : 0px;margin-bottom : 20px;}.fusion-builder-column-0 > .fusion-column-wrapper {padding-top : 0px !important;padding-right : 0px !important;margin-right : 1.92%;padding-bottom : 0px !important;padding-left : 0px !important;margin-left : 1.92%;}@media only screen and (max-width:1024px) {.fusion-body .fusion-builder-column-0{width:100% !important;order : 0;}.fusion-builder-column-0 > .fusion-column-wrapper {margin-right : 1.92%;margin-left : 1.92%;}}@media only screen and (max-width:640px) {.fusion-body .fusion-builder-column-0{width:100% !important;order : 0;}.fusion-builder-column-0 > .fusion-column-wrapper {margin-right : 1.92%;margin-left : 1.92%;}}<\/style><\/div><style type=\"text\/css\">.fusion-body .fusion-flex-container.fusion-builder-row-1{ padding-top : 0px;margin-top : 0px;padding-right : 0px;padding-bottom : 0px;margin-bottom : 0px;padding-left : 0px;}<\/style><\/div>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":9,"featured_media":2170,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"inline_featured_image":false,"footnotes":""},"categories":[22],"tags":[],"class_list":["post-2220","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-trazabilidad-en"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v23.3 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Migration of Serialization and Traceability L4 in the European<\/title>\n<meta name=\"description\" content=\"Discover why more pharmaceutical companies in Europe are seeking to migrate to more efficient L4 serialization providers with better support and lower long-term costs.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/blog.verifarma.com\/home\/trazabilidad-en\/migration-serialization-traceability-providers-european-pharmaceutical-industry-l4\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Migration of Serialization and Traceability L4 in the European\" \/>\n<meta property=\"og:description\" content=\"Discover why more pharmaceutical companies in Europe are seeking to migrate to more efficient L4 serialization providers with better support and lower long-term costs.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/blog.verifarma.com\/home\/trazabilidad-en\/migration-serialization-traceability-providers-european-pharmaceutical-industry-l4\/\" \/>\n<meta property=\"og:site_name\" content=\"BLOG\" \/>\n<meta property=\"article:published_time\" content=\"2024-11-07T12:30:08+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/blog.verifarma.com\/wp-content\/uploads\/2024\/04\/falsificacion-de-medicamentos.png\" \/>\n\t<meta property=\"og:image:width\" content=\"384\" \/>\n\t<meta property=\"og:image:height\" content=\"200\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Clara Massenzio\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Clara Massenzio\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/blog.verifarma.com\/home\/trazabilidad-en\/migration-serialization-traceability-providers-european-pharmaceutical-industry-l4\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/blog.verifarma.com\/home\/trazabilidad-en\/migration-serialization-traceability-providers-european-pharmaceutical-industry-l4\/\"},\"author\":{\"name\":\"Clara Massenzio\",\"@id\":\"https:\/\/blog.verifarma.com\/home\/#\/schema\/person\/48d9570e1c716ae3aaadb712442c0500\"},\"headline\":\"Why So Many Companies in Europe Are Reconsidering Their Traceability and Serialization Providers\",\"datePublished\":\"2024-11-07T12:30:08+00:00\",\"dateModified\":\"2024-11-07T12:30:08+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/blog.verifarma.com\/home\/trazabilidad-en\/migration-serialization-traceability-providers-european-pharmaceutical-industry-l4\/\"},\"wordCount\":1114,\"publisher\":{\"@id\":\"https:\/\/blog.verifarma.com\/home\/#organization\"},\"image\":{\"@id\":\"https:\/\/blog.verifarma.com\/home\/trazabilidad-en\/migration-serialization-traceability-providers-european-pharmaceutical-industry-l4\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/blog.verifarma.com\/wp-content\/uploads\/2024\/04\/falsificacion-de-medicamentos.png\",\"articleSection\":[\"Trazabilidad\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/blog.verifarma.com\/home\/trazabilidad-en\/migration-serialization-traceability-providers-european-pharmaceutical-industry-l4\/\",\"url\":\"https:\/\/blog.verifarma.com\/home\/trazabilidad-en\/migration-serialization-traceability-providers-european-pharmaceutical-industry-l4\/\",\"name\":\"Migration of Serialization and Traceability L4 in the European\",\"isPartOf\":{\"@id\":\"https:\/\/blog.verifarma.com\/home\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/blog.verifarma.com\/home\/trazabilidad-en\/migration-serialization-traceability-providers-european-pharmaceutical-industry-l4\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/blog.verifarma.com\/home\/trazabilidad-en\/migration-serialization-traceability-providers-european-pharmaceutical-industry-l4\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/blog.verifarma.com\/wp-content\/uploads\/2024\/04\/falsificacion-de-medicamentos.png\",\"datePublished\":\"2024-11-07T12:30:08+00:00\",\"dateModified\":\"2024-11-07T12:30:08+00:00\",\"description\":\"Discover why more pharmaceutical companies in Europe are seeking to migrate to more efficient L4 serialization providers with better support and lower long-term costs.\",\"breadcrumb\":{\"@id\":\"https:\/\/blog.verifarma.com\/home\/trazabilidad-en\/migration-serialization-traceability-providers-european-pharmaceutical-industry-l4\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/blog.verifarma.com\/home\/trazabilidad-en\/migration-serialization-traceability-providers-european-pharmaceutical-industry-l4\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/blog.verifarma.com\/home\/trazabilidad-en\/migration-serialization-traceability-providers-european-pharmaceutical-industry-l4\/#primaryimage\",\"url\":\"https:\/\/blog.verifarma.com\/wp-content\/uploads\/2024\/04\/falsificacion-de-medicamentos.png\",\"contentUrl\":\"https:\/\/blog.verifarma.com\/wp-content\/uploads\/2024\/04\/falsificacion-de-medicamentos.png\",\"width\":384,\"height\":200},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/blog.verifarma.com\/home\/trazabilidad-en\/migration-serialization-traceability-providers-european-pharmaceutical-industry-l4\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/blog.verifarma.com\/home\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Why So Many Companies in Europe Are Reconsidering Their Traceability and Serialization Providers\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/blog.verifarma.com\/home\/#website\",\"url\":\"https:\/\/blog.verifarma.com\/home\/\",\"name\":\"Verifarma\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/blog.verifarma.com\/home\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/blog.verifarma.com\/home\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/blog.verifarma.com\/home\/#organization\",\"name\":\"Verifarma\",\"url\":\"https:\/\/blog.verifarma.com\/home\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/blog.verifarma.com\/home\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/blog.verifarma.com\/wp-content\/uploads\/2020\/10\/verifarma-blog-logo.png\",\"contentUrl\":\"https:\/\/blog.verifarma.com\/wp-content\/uploads\/2020\/10\/verifarma-blog-logo.png\",\"width\":227,\"height\":57,\"caption\":\"Verifarma\"},\"image\":{\"@id\":\"https:\/\/blog.verifarma.com\/home\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.linkedin.com\/company\/bdev-sa\/\",\"https:\/\/www.youtube.com\/channel\/UCucXK5o8YRbnyfqv9N6k6xA\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/blog.verifarma.com\/home\/#\/schema\/person\/48d9570e1c716ae3aaadb712442c0500\",\"name\":\"Clara Massenzio\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/blog.verifarma.com\/home\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/93f9e4a482f1cda0a1d385c1e01e0ddb?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/93f9e4a482f1cda0a1d385c1e01e0ddb?s=96&d=mm&r=g\",\"caption\":\"Clara Massenzio\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Migration of Serialization and Traceability L4 in the European","description":"Discover why more pharmaceutical companies in Europe are seeking to migrate to more efficient L4 serialization providers with better support and lower long-term costs.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/blog.verifarma.com\/home\/trazabilidad-en\/migration-serialization-traceability-providers-european-pharmaceutical-industry-l4\/","og_locale":"en_US","og_type":"article","og_title":"Migration of Serialization and Traceability L4 in the European","og_description":"Discover why more pharmaceutical companies in Europe are seeking to migrate to more efficient L4 serialization providers with better support and lower long-term costs.","og_url":"https:\/\/blog.verifarma.com\/home\/trazabilidad-en\/migration-serialization-traceability-providers-european-pharmaceutical-industry-l4\/","og_site_name":"BLOG","article_published_time":"2024-11-07T12:30:08+00:00","og_image":[{"width":384,"height":200,"url":"https:\/\/blog.verifarma.com\/wp-content\/uploads\/2024\/04\/falsificacion-de-medicamentos.png","type":"image\/png"}],"author":"Clara Massenzio","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Clara Massenzio","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/blog.verifarma.com\/home\/trazabilidad-en\/migration-serialization-traceability-providers-european-pharmaceutical-industry-l4\/#article","isPartOf":{"@id":"https:\/\/blog.verifarma.com\/home\/trazabilidad-en\/migration-serialization-traceability-providers-european-pharmaceutical-industry-l4\/"},"author":{"name":"Clara Massenzio","@id":"https:\/\/blog.verifarma.com\/home\/#\/schema\/person\/48d9570e1c716ae3aaadb712442c0500"},"headline":"Why So Many Companies in Europe Are Reconsidering Their Traceability and Serialization Providers","datePublished":"2024-11-07T12:30:08+00:00","dateModified":"2024-11-07T12:30:08+00:00","mainEntityOfPage":{"@id":"https:\/\/blog.verifarma.com\/home\/trazabilidad-en\/migration-serialization-traceability-providers-european-pharmaceutical-industry-l4\/"},"wordCount":1114,"publisher":{"@id":"https:\/\/blog.verifarma.com\/home\/#organization"},"image":{"@id":"https:\/\/blog.verifarma.com\/home\/trazabilidad-en\/migration-serialization-traceability-providers-european-pharmaceutical-industry-l4\/#primaryimage"},"thumbnailUrl":"https:\/\/blog.verifarma.com\/wp-content\/uploads\/2024\/04\/falsificacion-de-medicamentos.png","articleSection":["Trazabilidad"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/blog.verifarma.com\/home\/trazabilidad-en\/migration-serialization-traceability-providers-european-pharmaceutical-industry-l4\/","url":"https:\/\/blog.verifarma.com\/home\/trazabilidad-en\/migration-serialization-traceability-providers-european-pharmaceutical-industry-l4\/","name":"Migration of Serialization and Traceability L4 in the European","isPartOf":{"@id":"https:\/\/blog.verifarma.com\/home\/#website"},"primaryImageOfPage":{"@id":"https:\/\/blog.verifarma.com\/home\/trazabilidad-en\/migration-serialization-traceability-providers-european-pharmaceutical-industry-l4\/#primaryimage"},"image":{"@id":"https:\/\/blog.verifarma.com\/home\/trazabilidad-en\/migration-serialization-traceability-providers-european-pharmaceutical-industry-l4\/#primaryimage"},"thumbnailUrl":"https:\/\/blog.verifarma.com\/wp-content\/uploads\/2024\/04\/falsificacion-de-medicamentos.png","datePublished":"2024-11-07T12:30:08+00:00","dateModified":"2024-11-07T12:30:08+00:00","description":"Discover why more pharmaceutical companies in Europe are seeking to migrate to more efficient L4 serialization providers with better support and lower long-term costs.","breadcrumb":{"@id":"https:\/\/blog.verifarma.com\/home\/trazabilidad-en\/migration-serialization-traceability-providers-european-pharmaceutical-industry-l4\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/blog.verifarma.com\/home\/trazabilidad-en\/migration-serialization-traceability-providers-european-pharmaceutical-industry-l4\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/blog.verifarma.com\/home\/trazabilidad-en\/migration-serialization-traceability-providers-european-pharmaceutical-industry-l4\/#primaryimage","url":"https:\/\/blog.verifarma.com\/wp-content\/uploads\/2024\/04\/falsificacion-de-medicamentos.png","contentUrl":"https:\/\/blog.verifarma.com\/wp-content\/uploads\/2024\/04\/falsificacion-de-medicamentos.png","width":384,"height":200},{"@type":"BreadcrumbList","@id":"https:\/\/blog.verifarma.com\/home\/trazabilidad-en\/migration-serialization-traceability-providers-european-pharmaceutical-industry-l4\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/blog.verifarma.com\/home\/"},{"@type":"ListItem","position":2,"name":"Why So Many Companies in Europe Are Reconsidering Their Traceability and Serialization Providers"}]},{"@type":"WebSite","@id":"https:\/\/blog.verifarma.com\/home\/#website","url":"https:\/\/blog.verifarma.com\/home\/","name":"Verifarma","description":"","publisher":{"@id":"https:\/\/blog.verifarma.com\/home\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/blog.verifarma.com\/home\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/blog.verifarma.com\/home\/#organization","name":"Verifarma","url":"https:\/\/blog.verifarma.com\/home\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/blog.verifarma.com\/home\/#\/schema\/logo\/image\/","url":"https:\/\/blog.verifarma.com\/wp-content\/uploads\/2020\/10\/verifarma-blog-logo.png","contentUrl":"https:\/\/blog.verifarma.com\/wp-content\/uploads\/2020\/10\/verifarma-blog-logo.png","width":227,"height":57,"caption":"Verifarma"},"image":{"@id":"https:\/\/blog.verifarma.com\/home\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.linkedin.com\/company\/bdev-sa\/","https:\/\/www.youtube.com\/channel\/UCucXK5o8YRbnyfqv9N6k6xA"]},{"@type":"Person","@id":"https:\/\/blog.verifarma.com\/home\/#\/schema\/person\/48d9570e1c716ae3aaadb712442c0500","name":"Clara Massenzio","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/blog.verifarma.com\/home\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/93f9e4a482f1cda0a1d385c1e01e0ddb?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/93f9e4a482f1cda0a1d385c1e01e0ddb?s=96&d=mm&r=g","caption":"Clara Massenzio"}}]}},"_links":{"self":[{"href":"https:\/\/blog.verifarma.com\/home\/wp-json\/wp\/v2\/posts\/2220"}],"collection":[{"href":"https:\/\/blog.verifarma.com\/home\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blog.verifarma.com\/home\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blog.verifarma.com\/home\/wp-json\/wp\/v2\/users\/9"}],"replies":[{"embeddable":true,"href":"https:\/\/blog.verifarma.com\/home\/wp-json\/wp\/v2\/comments?post=2220"}],"version-history":[{"count":1,"href":"https:\/\/blog.verifarma.com\/home\/wp-json\/wp\/v2\/posts\/2220\/revisions"}],"predecessor-version":[{"id":2221,"href":"https:\/\/blog.verifarma.com\/home\/wp-json\/wp\/v2\/posts\/2220\/revisions\/2221"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/blog.verifarma.com\/home\/wp-json\/wp\/v2\/media\/2170"}],"wp:attachment":[{"href":"https:\/\/blog.verifarma.com\/home\/wp-json\/wp\/v2\/media?parent=2220"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blog.verifarma.com\/home\/wp-json\/wp\/v2\/categories?post=2220"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blog.verifarma.com\/home\/wp-json\/wp\/v2\/tags?post=2220"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}